These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22229310)

  • 1. Nicotine vaccines.
    Fahim RE; Kessler PD; Fuller SA; Kalnik MW
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):905-15. PubMed ID: 22229310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in vaccines against nicotine addiction].
    Wang GB; Zhu CJ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1189-94. PubMed ID: 24187824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic vaccines against tobacco addiction.
    Fahim RE; Kessler PD; Kalnik MW
    Expert Rev Vaccines; 2013 Mar; 12(3):333-42. PubMed ID: 23496672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic vaccines for nicotine dependence.
    Maurer P; Bachmann MF
    Curr Opin Mol Ther; 2006 Feb; 8(1):11-6. PubMed ID: 16506520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against nicotine: an emerging therapy for tobacco dependence.
    Maurer P; Bachmann MF
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1775-83. PubMed ID: 17970637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine vaccines to assist with smoking cessation: current status of research.
    Raupach T; Hoogsteder PH; Onno van Schayck CP
    Drugs; 2012 Mar; 72(4):e1-16. PubMed ID: 22356293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
    Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR
    Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine conjugate vaccine as a novel approach to smoking cessation.
    Ottney AR
    Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial.
    Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; van Schayck OC
    Addiction; 2014 Aug; 109(8):1252-9. PubMed ID: 24894625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine vaccines to treat tobacco dependence.
    Goniewicz ML; Delijewski M
    Hum Vaccin Immunother; 2013 Jan; 9(1):13-25. PubMed ID: 23108361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expecting the antinicotine vaccine].
    Didilescu C
    Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting nicotine addiction: the possibility of a therapeutic vaccine.
    Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM
    Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder.
    Hicks TA; Thomas SP; Wilson SM; Calhoun PS; Kuhn ER; Beckham JC
    J Dual Diagn; 2017; 13(1):15-20. PubMed ID: 27918881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
    Hatsukami DK; Jorenby DE; Gonzales D; Rigotti NA; Glover ED; Oncken CA; Tashkin DP; Reus VI; Akhavain RC; Fahim RE; Kessler PD; Niknian M; Kalnik MW; Rennard SI
    Clin Pharmacol Ther; 2011 Mar; 89(3):392-9. PubMed ID: 21270788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial.
    Tonstad S; Heggen E; Giljam H; Lagerbäck PÅ; Tønnesen P; Wikingsson LD; Lindblom N; de Villiers S; Svensson TH; Fagerström KO
    Nicotine Tob Res; 2013 Sep; 15(9):1492-501. PubMed ID: 23471101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines against nicotine: how effective are they likely to be in preventing smoking?
    Vocci FJ; Chiang CN
    CNS Drugs; 2001; 15(7):505-14. PubMed ID: 11510621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nicotine abuse vaccines in the pipeline: an update.
    Cerny EH; Cerny T
    Expert Opin Investig Drugs; 2008 May; 17(5):691-6. PubMed ID: 18447595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the protective effects of a conformationally constrained nicotine vaccine.
    Moreno AY; Azar MR; Koob GF; Janda KD
    Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current and future medical drugs for smoking cessation].
    Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
    Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.